Novartis expects the new capacity will allow it to produce all of its key medicines “end to end” in the U.S., as the Trump administration buffets global trade with tariffs.
Categories:
Related Post
House committee advances bill with ‘big three’ business tax relief
The bill advanced Wednesday by the House Ways and Means Committee would extend some business-friendly…
Cash isn’t king. Cash flow is.
Smart contractors know how long it takes for money to transform from an outgoing expense…
Surety industry sees education as key to opening doors for new construction firms
New contractors often face hurdles seeking bonds—the surety industry’s education efforts seek to change that.